Identification of the cancer biomarkers Estrogen Receptor (ER), Progesterone Receptor (PR) and the oncoprotein Human Epidermal Growth Factor Receptor 2 (HER2) aid in characterizing tumor type, predicting prognosis and defining treatment, since they are important therapeutic targets of chemotherapeutic drugs [4]. This evidence concerns the gene ERBB2 and neoplasm.